203 related articles for article (PubMed ID: 13788170)
1. Some remarks about monoamine oxidase and monoamine oxidase inhibitors.
ZELLER EA
J Neuropsychiatr; 1961 Feb; 2(Suppl 1)():125-30. PubMed ID: 13788170
[No Abstract] [Full Text] [Related]
2. Specific liver and brain monoamine oxidase inhibition by alkyl- and arylalkylhydrazines.
HORITA A; McGRATH WR
Proc Soc Exp Biol Med; 1960 Apr; 103():753-7. PubMed ID: 14403108
[No Abstract] [Full Text] [Related]
3. Response of chronic schizophrenics to a monoamine oxidase inhibitor.
GUERTIN WH; REGNIER WO; GOOD RW; NICHOLSON G
Dis Nerv Syst; 1960 Jun; 21():330-2. PubMed ID: 13830070
[No Abstract] [Full Text] [Related]
4. Comparative effects of monoamine oxidase inhibitors on monoamine oxidase and diamine oxidase.
SHORE PA; COHN VH
Biochem Pharmacol; 1960 Oct; 5():91-5. PubMed ID: 13912256
[No Abstract] [Full Text] [Related]
5. Effect of the combined administration of imipramine and a monoamine oxidase inhibitor.
HIMWICH WA; PETERSEN JC
Am J Psychiatry; 1961 Apr; 117():928-9. PubMed ID: 13714420
[No Abstract] [Full Text] [Related]
6. [Clinical experiences with monoamine oxidase inhibitors and other substances controlling serotonin metabolism].
CONSBRUCH U; FAUST C
Psychiatr Neurol (Basel); 1960 Jul; 140():76-82. PubMed ID: 13695106
[No Abstract] [Full Text] [Related]
7. Monoamine oxidase inhibition.
ROSENBLUM I; FERGUSON FC
Clin Pharmacol Ther; 1960; 1():692-3. PubMed ID: 13743428
[No Abstract] [Full Text] [Related]
8. Studies on monoamine oxidase. 2: p-Methylphenyl hydrazine, a potent and selective monoamine oxidase inhibitor.
ARAI A
Jpn J Pharmacol; 1960 Mar; 9():159-68. PubMed ID: 13683948
[No Abstract] [Full Text] [Related]
9. Pharmacologic aspects of monoamine oxidase inhibition.
WEBB JL
Am J Cardiol; 1960 Dec; 6():1112-6. PubMed ID: 13783566
[No Abstract] [Full Text] [Related]
10. Monoamine oxidase, psychoenergizers, and tranquilizers.
FELDSTEIN A; HOAGLAND H; FREEMAN H
Science; 1959 Aug; 130(3374):500. PubMed ID: 13822065
[TBL] [Abstract][Full Text] [Related]
11. Histochemical demonstration in rat of monoamine oxidase inhibition of beta-phenyl-isopropyl hydrazine.
MUSTAKALLIO KK; LEVONEN E; RAEKALLIO J
Science; 1961 Aug; 134(3475):344. PubMed ID: 13727138
[TBL] [Abstract][Full Text] [Related]
12. [Our experiences with monoamine oxidase inhibiting substances].
TAUBER CG
Psychiatr Neurol (Basel); 1960 Jul; 140():148-51. PubMed ID: 13775480
[No Abstract] [Full Text] [Related]
13. Significance of monoamine oxidase inhibition for the pharmacological and clinical effects of hydrazine derivatives.
PLETSCHER A
Ann N Y Acad Sci; 1959 Sep; 80():1039-45. PubMed ID: 14433482
[No Abstract] [Full Text] [Related]
14. A method for measurement of monoamine oxidase inhibition in man: application to studies on hypertension.
SJOERDSMA A; GILLESPIE L; UDENFRIEND S
Ann N Y Acad Sci; 1959 Sep; 80():969-80. PubMed ID: 13831423
[No Abstract] [Full Text] [Related]
15. In vivo metabolism of serotonin and tryptamine: effect of monoamine oxidase inhibition.
WEISSBACH H; LOVENBERG W; REDFIELD BG; UDENFRIEND S
J Pharmacol Exp Ther; 1961 Jan; 131():26-30. PubMed ID: 13784114
[No Abstract] [Full Text] [Related]
16. Toxicity from large doses of imipramine and an MAO inhibitor in suicidal intent.
LUBY ED; DOMINO EF
JAMA; 1961 Jul; 177():68-9. PubMed ID: 13763947
[No Abstract] [Full Text] [Related]
17. The route of administration of some hydrazine compounds as a determinant of brain and liver monoamine oxidase inhibition.
HORITA A
Toxicol Appl Pharmacol; 1961 Jul; 3():474-80. PubMed ID: 13715854
[No Abstract] [Full Text] [Related]
18. In vivo monoamine oxidase inhibition measured by potentiation of tryptamine convulsions in rats.
TEDESCHI DH; TEDESCHI RE; FELLOWS EJ
Proc Soc Exp Biol Med; 1960 Apr; 103():680-2. PubMed ID: 13837257
[No Abstract] [Full Text] [Related]
19. A clinical and biochemical study of monoamine oxidase inhibition in depressed patients. I. A clinical trial of Nialamide.
DEWHURST WG; PARE CM
J Ment Sci; 1961 Mar; 107():239-43. PubMed ID: 13722403
[No Abstract] [Full Text] [Related]
20. Metabolism of adrenaline after blockade of monoamine oxidase and catechol-O-methyltransferase.
DE SCHAEPDRYVER AF; KIRSHNER N
Science; 1961 Feb; 133(3452):586-7. PubMed ID: 13720844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
